FATE stock

Fate Therapeutics Inc (FATE) financials · rev $6.6M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Fate Therapeutics Inc (FATE) rev $6.6M.

Cached annual income statement
LineFY2025FY2024
Revenue$6.65M$13.6M
Operating Income-$147.7M-$210.3M
Net Income-$136.3M-$186.3M
EPS (Diluted)-$1.15-$1.64
Cached annual balance sheet
LineFY2025FY2024
Total Assets$318.9M$440.7M
Current Assets$208.7M$291.9M
Cash & Equivalents$46.6M$36.1M
PP&E$56.9M$64.4M
Total Liabilities$111.8M$122.0M
Current Liabilities$36.1M$38.5M
Shareholders' Equity$207.2M$318.7M
Retained Earnings-$1.53B-$1.40B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$106.1M-$122.9M
CapEx$5.95M$730.0K
Investing Cash Flow$111.2M$12.2M
Financing Cash Flow$5.49M$99.9M
Net Change in Cash$10.6M-$10.8M
Free Cash Flow-$112.0M-$123.6M
These statements as JSON? API free 100/day

FAQ

What is FATE P/E and revenue?

Fate Therapeutics Inc (FATE) rev $6.6M.

What is FATE revenue?

Fate Therapeutics Inc last cached revenue is $6.65M (FY2025).

Is FATE profitable?

Fate Therapeutics Inc last cached net income is -$136.3M (FY2025).

What are FATE total assets?

Fate Therapeutics Inc last cached total assets are $318.9M (FY2025).

What is FATE free cash flow?

Fate Therapeutics Inc last cached free cash flow is -$112.0M (FY2025).

Not investment advice. Cached statements, not a live tape.